Navigation Links
Mount Sinai Hospital researcher makes stem cell breakthrough

(Toronto, ON, February 25, 2009) In a study to be released on March 1, 2009, Mount Sinai Hospital's Dr. Andras Nagy discovered a new method of creating stem cells that could lead to possible cures for devastating diseases including spinal cord injury, macular degeneration, diabetes and Parkinson's disease. The study, to be published by Nature online, accelerates stem cell technology and provides a road map for new clinical approaches to regenerative medicine.

"We hope that these stem cells will form the basis for treatment for many diseases and conditions that are currently considered incurable," said Dr. Nagy, Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Investigator at the McEwen Centre for Regenerative Medicine, and Canada Research Chair in Stem Cells and Regeneration. "This new method of generating stem cells does not require embryos as starting points and could be used to generate cells from many adult tissues such as a patient's own skin cells."

Dr. Nagy discovered a new method to create pluripotent stem cells (cells that can develop into most other cell types) without disrupting healthy genes. Dr. Nagy's method uses a novel wrapping procedure to deliver specific genes to reprogram cells into stem cells. Previous approaches required the use of viruses to deliver the required genes, a method that carries the risk of damaging the DNA. Dr. Nagy's method does not require viruses, and so overcomes a major hurdle for the future of safe, personalized stem cell therapies in humans.

"This research is a huge step forward on the path to new stem cell-based therapies and indicates that researchers at the Lunenfeld are at the leading edge of regenerative medicine," said Dr. Jim Woodgett, Director of Research for the Samuel Lunenfeld Research Institute of Mount Sinai Hospital. Regenerative medicine refers to enabling the human body to repair, replace, restore and regenerate its own damaged or diseased cells, tissues and organs.

The research was funded by the Canadian Stem Cell Network and the Juvenile Diabetes Research Foundation (United States).

Dr. Nagy joined Mount Sinai Hospital as a Principal investigator in 1994. In 2005, he created Canada's first embryonic stem cell lines from donated embryos no longer required for reproduction by couples undergoing fertility treatment. That research played a pivotal role in Dr. Nagy's current discovery.

One of the critical components reported in Nagy's paper was developed in the laboratory of Dr. Keisuke Kaji from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh. Dr. Kaji's findings are also published in the March 1, 2009 issue of Nature. The two papers are highly complementary and further extend Nagy's findings.

"I was very excited when I found stem cell-like cells in my culture dishes. Nobody, including me, thought it was really possible," said Dr. Kaji. "It is a step towards the practical use of reprogrammed cells in medicine."


Contact: Nikki Luscombe
416-586-4800 x2046
Samuel Lunenfeld Research Institute

Related biology news :

1. Will large amounts of soil carbon be released if grasslands are converted to energy crops?
2. Mountain caribous ancient ancestry revealed
3. Escherichia coli bacteria transferring between humans and mountain gorillas
4. Mounting evidence shows health benefits of grape polyphenols
5. Missouri Botanical Garden mounts milestone 6 millionth herbarium specimen
6. Tropical rainforest and mountain species may be threatened by global warming
7. White Mountain Research Station to host climate change conference
8. Radioactivity: Discover the lowest amounts with new methods
9. International experts collect alpine fungi in Beartooth Mountains of Montana
10. New once-a-week treatment for type 2 diabetes developed by Mount Sinai researcher
11. Mount Sinai researchers discover technology that silences genes
Post Your Comments:
(Date:10/6/2015)... , Oct. 6, 2015  Maverix Biomics, ... announced enhancements to its software portfolio with the ... kit for differential expression in eukaryotes. The software ... is a cloud-based genomic analysis solution that leverages ... discovery from next-generation sequencing efforts. Garry ...
(Date:10/1/2015)... Oct. 1, 2015  Biometrics includes diverse set ... body characteristics, such as fingerprints, eye retinas, facial ... of biometrics technology has been constantly increasing in ... five years. In addition to the most prominent ... recognition, other means of biometric authentication are rapidly ...
(Date:9/30/2015)... Sept. 30, 2015  The global glucose monitoring device and ... So says a new report on the industry from Kalorama ... dominate the market, followed by continuous glucose monitoring and sensor ... the market for these products in its latest report, ... , ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... and TORONTO , Oct. 13, ... today announced that it has entered into a non-binding Letter ... a private Israeli company that has developed a proprietary cooling ... due to varicoceles. the United States ... between the ages of 25 and 44 diagnosed as ...
(Date:10/13/2015)... ... October 13, 2015 , ... Clinovo recently appointed Jeff ... the company’s fast growing clinical data solutions business. , Jeff Parr has spent the ... all sizes, including Avery Dennison, Thermo Fisher, and Ab Sciex to name a few. ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... personalized medicine, is excited to announce their partnership with the Keck Medicine ... genetics of chronic pain. , The T.R.O.J.A.N. Study (Therapeutic Evaluation to Research Clinical ...
(Date:10/13/2015)... the United States , Canada ... all new cases of kidney cancer.   --> ... Europe .  PRCC represents about 14% of all ... MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison MediPharma Limited ... completed enrolment in a global Phase II study of savolitinib (AZD6094), ...
Breaking Biology Technology: